Leading experts in CF discuss how the discovery of the CFTR gene has changed patient care, even if it’s much slower than they anticipated. Further, they share their frustrations over the years as the discovery did not meet the initial expectations after the discovery.
Related Videos In Cystic Fibrosis
Jennifer Taylor-Cousar, April 2020 – COVID-19 and Cystic Fibrosis
Dr Jennifer Taylor-Cousar (National Jewish Health, Denver, CO, USA) explores what we have learnt so far about how COVID-19 is effecting patients with cystic fibrosis. Questions 1. What is the risk to cystic fibrosis patients from COVID-19 and what have we learned from reported cases so far? (0:07) 2. It seems that, to date, cystic […]
Plasma Biomarkers to Determine Severity of Lung Function in CF
During the 36th Annual European Cystic Fibrosis Conference held in Lisbon, Drs. Peter Mogayzel and Kenneth Olivier, Staff Clinician at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, discuss importance of mycobacterium in CF. Dr. Olivier also discusses the new NTM guidelines that are being developed.
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!